Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6
- PMID: 22271344
- DOI: 10.1007/s00406-012-0290-2
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6
Abstract
Several studies have shown an involvement of the immune system, in particular the monocytic system, in the pathophysiology of schizophrenia. Beside others, the monocyte-derived cytokines TNF-α, IL-6 and IL-10 were found to be affected. Since cytokines are secreted by several different cell types, the cellular source is only clear if intracellular levels are measured. Thus, in order to study the monocytic system in schizophrenia, the intracellular levels of TNF-α, IL-6 and IL-10 were determined. The intracellular concentration of TNF-α, IL-6 and IL-10 in CD33 positive monocytes was evaluated in schizophrenic patients and controls with monoclonal antibodies against these cytokines. In addition, in vitro stimulation with lipopolysaccharide (LPS) or poly I/C, which mimic a bacterial and viral infection, was performed before immunocytochemistry. At baseline, monocytic IL-6 levels were significantly lower in schizophrenic patients than in controls. After stimulation with LPS, compared with baseline, monocytic intracellular IL-6 production tended to increase more in schizophrenic patients. The present results provide further support for the hypothesis of an involvement of a dysfunction of the monocytic system in the pathophysiology of schizophrenia and indicate that especially the pro-inflammatory immune response seems to be impaired.
Similar articles
-
Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia.Neuropsychobiology. 2007;56(2-3):55-63. doi: 10.1159/000111535. Epub 2007 Nov 23. Neuropsychobiology. 2007. PMID: 18037815
-
Secreted and intracellular cytokines are complementary measures for human monocytes treated with Toll-like receptor agonists.J Immunol Methods. 2019 Jan;464:131-137. doi: 10.1016/j.jim.2018.11.003. Epub 2018 Nov 3. J Immunol Methods. 2019. PMID: 30395817
-
Impaired monocyte activation in schizophrenia.Psychiatry Res. 2012 Aug 15;198(3):341-6. doi: 10.1016/j.psychres.2011.12.049. Epub 2012 Mar 17. Psychiatry Res. 2012. PMID: 22429483
-
Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.Rheumatology (Oxford). 2003 Apr;42(4):541-8. doi: 10.1093/rheumatology/keg171. Rheumatology (Oxford). 2003. PMID: 12649401 Clinical Trial.
-
[Cytokines in children with immunodeficiencies].Folia Med Cracov. 1999;40(1-2):5-97. Folia Med Cracov. 1999. PMID: 10909468 Review. Polish.
Cited by
-
Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production.Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):417-426. doi: 10.1007/s00406-017-0782-1. Epub 2017 Mar 17. Eur Arch Psychiatry Clin Neurosci. 2017. PMID: 28314932
-
Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings.Cells. 2023 Aug 19;12(16):2099. doi: 10.3390/cells12162099. Cells. 2023. PMID: 37626909 Free PMC article. Review.
-
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Neuropsychopharmacology. 2017 Jan;42(1):299-317. doi: 10.1038/npp.2016.211. Epub 2016 Sep 22. Neuropsychopharmacology. 2017. PMID: 27654215 Free PMC article. Review.
-
Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.Biol Psychiatry. 2013 May 15;73(10):993-9. doi: 10.1016/j.biopsych.2012.09.007. Epub 2012 Oct 11. Biol Psychiatry. 2013. PMID: 23062357 Free PMC article.
-
Biomarkers and neurobiology of schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):363-4. doi: 10.1007/s00406-012-0340-9. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 22743736 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical